Lilli Petruzzelli is a natural problem-solver, constantly exploring new ways to tackle the most complex challenges in drug discovery for patients. She also finds balance in life’s simple joys—like spending time with family and baking. As Senior Vice President of Early Clinical Development, Lilli has woven her love of chemistry, dedication to patient care, and passion for problem-solving into a career that bridges research, medicine, and heart. http://spr.ly/61820Wylg | Genentech

At Genentech, we push the boundaries of science, always striving for breakthroughs that could change the future for people living with cancer. With breast cancer affecting millions of people, the need for new medicines inspires our team to give their best every day. Hear their stories on what working in breast cancer means to them. #BreastCancerAwarenessMonth | Genentech

Felicia is making the most of life even with stage 4, metastatic HER2-positive breast cancer. The outpouring of love and support from her church community empowers her to continue treatment. Watch her video below. #BreastCancerAwarenessMonth | Genentech

Julia, diagnosed HER2-positive, explains why it's important for everyone to understand that breast cancer is not a one-size-fits-all disease. Watch as she shares why being more informed is important for both patients and their loved ones. https://bit.ly/2uqk2JV | Genentech

Biomarker testing was an important part of Shirley’s cancer journey. When she was diagnosed with cancer in her early 30s, her doctors tested her cancer for biomarkers. The results showed a mutation called ALK. With this knowledge, her doctors were able to develop a plan to treat her specific cancer. Learn more about biomarker testing and Shirley’s story: https://bit.ly/3sTw9AR | Genentech

Biomarker testing is a critical step to receiving a complete lung cancer diagnosis and may help guide treatment decisions. However, a significant number of people with lung cancer aren’t aware of biomarker testing and don’t know to ask for it. When Nikki received her lung cancer diagnosis, her doctor suggested they test her right away for certain biomarkers such as ALK. Listen to Nikki’s story and learn about the importance of talking to a healthcare provider about biomarker testing. Learn more